Іntravesical hyperthermic chemotherapy with mitomycin c in patients with non-muscle-invasive bladder cancer, initial experience in a single center

Kostev, F.I. and Chystiakov, R.S. and Lysenko, V.V. and Stavnychyi, O.S. and Rosha, L.G. (2019) Іntravesical hyperthermic chemotherapy with mitomycin c in patients with non-muscle-invasive bladder cancer, initial experience in a single center. Урологія, 23 (1(88)). p. 78. ISSN 2307-5279

Text INTRAVESICAL HYPERTHERMIC CHEMOTHERAPY.pdf Download (134kB)

Abstract

The EUA 2018 guidelines recommend that patients with high-risk NMIBC receive either intravesical BCG or radical cystectomy. BCG therapy is difficult to tolerate by patients and some patients are not suitable for cystectomy. The hyperthermic intravesical chemotherapy (HIVEC) can be an alternative method for this category of patients, and a large number of studies currently underway confirms this. HIVEC is presented in EAU Guidelines 2018 for non-muscle-invasive bladder cancer. We present the early results of our series in patients treated with COMBAT BRS-HIVEC recirculation system.

Item Type:	Article
Additional Information:	Матеріали VIII Міжнародного конгресу спілки онкоурологів України СОУУ-2019 «Досягнення і перспективи в онкоурології, пластичній та реконструктивній хірургії сечовивідних шляхів». м. Київ, 11-13 квітня 2019 р.
Subjects:	Urology Oncology
Divisions:	University periodicals > Урологія
Depositing User:	Аліна Чеботарьова
Date Deposited:	13 May 2022 09:39
Last Modified:	07 Sep 2022 09:45
URI:	http://repo.dma.dp.ua/id/eprint/7493

Actions (login required)

View Item